News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Filters
PharmaDrug Announces Filing of US Provisional Patent for Cepharanthine to Treat Prostate Cancer
Pharmadrug Inc.
Psyched Wellness Announces Launch of New Logo, Branding, and Website, Prepares to Release Industry-First Amanita Muscaria Tincture
Psyched Wellness
Field Trip Health Ltd. Schedules Third Fiscal Quarter 2022 Financial Results Conference Call for February 16, 2022 at 8:30 AM ET
Field Trip Health
Braxia Scientific Provides Update on Large Proprietary Dataset Expected to Support Pharmaceutical and Industry Clinical Trials for Ketamine and Psilocybin Drug Development
Braxia Scientific Corp.
Clearmind Medicine Now Fully Eligible for Settlement through the Depository Trust Company (“DTC”)
Clearmind Medicine
Filament Health And Cybin Therapeutics Announce Approval For Phase II Clinical Trial For Depression
Filament Health
Cybin Inc.
Clearmind Medicine Partners with Dr. Gabor Maté to Discuss Alcohol Use Disorder and Trauma in a Special Virtual Event on February 3
Clearmind Medicine
Red Light Holland's Partner CCrest Laboratories Approved By Health Canada to Supply Psilocybin to the Special Access Program
Red Light Holland
Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent Application for Idiopathic Pulmonary Fibrosis
Algernon Pharmaceuticals
Enveric Biosciences to Participate in Upcoming Investor Conferences in February 2022
Enveric Biosciences
atai Life Sciences Launches Invyxis to Accelerate Discovery of Next-Generation Mental Health Treatments
ATAI Life Sciences
Nova Mentis and KGK Science Form Tactical Partnership
Nova Mentis Life Science
Novamind Announces Closing of CAD$5 Million Private Placement with Institutional Investor
Novamind Inc.
Cybin to Announce Third Quarter Financial Results and Business Update on February 10, 2022
Cybin Inc.
Wellbeing Digital Sciences’ Subsidiary KGK Science Forms Tactical Partnership with Nova Mentis
Wellbeing Digital Sciences
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.